Asclepius Ventures

Asclepius Ventures LLC is a healthcare-focused venture capital firm dedicated to advancing the commercialization of proven healthcare technologies. Led by David Jahns, who is also Managing Partner at Galen Partners, Asclepius Ventures brings deep industry expertise and strategic guidance to innovative companies poised for growth. The firm partners with entrepreneurs and healthcare leaders to scale solutions that reduce costs, improve clinical outcomes, and transform care delivery. By aligning capital with mission-driven innovation, Asclepius Ventures is committed to accelerating the impact of next-generation healthcare solutions. Investment Criteria At Asclepius Ventures, we invest in early-stage healthcare companies that are ready to scale. Our focus is on businesses with proven, technology-driven solutions that are already making a measurable impact on clinical outcomes and cost efficiencies. We seek to partner with companies that meet the following core criteria: Revenue Traction Annual Recurring Revenue (ARR) exceeding $5 million, demonstrating strong product-market fit and the ability to generate predictable, recurring revenue. Validated Technology or Tech-Enabled Solutions Innovations that have moved beyond the conceptual phase and are being actively used to address unmet needs across the healthcare ecosystem. Data-Driven Leadership Experienced and analytical management teams who make decisions grounded in data and measurable performance metrics. Purpose-Driven Culture Organizations that foster a culture of creativity, accountability, and mission alignment, focused on delivering lasting value to patients, providers, and payers.